EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

State-of-the-Art Review: Managing Vulvovaginal Candidiasis

Riina Rautemaa-Richardson iD, Jack D Sobel iD, Neil Stone iD, Francesco De Seta, Antonio Cassone iD, Pedro Vieira-Baptista, Manola Comar, Adilia Warris iD, Elena Roselletti iD

Clinical Infectious Diseases · 17.03.2026 · 82 (3) · 371-382

DOI: 10.1093/cid/ciaf673 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 17.03.2026. Verfasst von Riina Rautemaa-Richardson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mycology Reference Centre Manchester and Department of Infectious Diseases, ECMM Centre of Excellence, Manchester Academic Health Science Centre, Wyt…. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Antifungal Agents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC Centre for Medical Mycology, University of Exeter, NIHR Exeter Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvovaginal candidiasis is one of the most prevalent infections in women worldwide. Together with its recurrent form, it affects millions of women annually, causing significant symptoms and severely impacting quality of life. This review examines the pathophysiology, risk factors, microbiome interactions, clinical manifestations, and challenges in diagnosing and managing vulvovaginal candidiasis, with emphasis on recurrent vulvovaginal candidiasis. While Candida albicans is the primary cause, non-albicans species are increasingly common. Multiple factors contribute to both forms, including hormonal changes, diabetes, antibiotic use, immune dysfunction, and genetics. The vaginal microbiome plays a key role in maintaining homeostasis and preventing Candida overgrowth. Symptoms such as itching, discharge, and soreness overlap with other conditions, complicating the diagnosis. Standard treatment involves topical or systemic antifungals, but recurrence and resistance are frequent. Emerging strategies include novel antifungals, immunomodulators, and vaccines. Future approaches should focus on modulating host and environmental factors to prevent recurrence, reduce resistance, and improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalAntifungal AgentsHumansFemaleMicrobiotaRisk FactorsVaginaRecurrenceDrug Resistance, Fungal

Stichwörter der Autor:innen

Candidaantifungal and emerging therapiesrecurrencesvaginal microbiomevulvovaginal candidiasis

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Mycology Reference Centre Manchester and Department of Infectious Diseases, ECMM Centre of Excellence, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manches…
  • Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Hospital for Tropical Diseases/University College London Hospitals Infection Division, London, United Kingdom.
  • Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United Kingdom.
  • Department of Obstetrics and Gynaecology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

ORCID-Profile: Riina Rautemaa-Richardson, Jack D Sobel, Neil Stone, Antonio Cassone, Adilia Warris, Elena Roselletti

Förderung

  • MRC Centre for Medical Mycology
  • University of Exeter
  • NIHR Exeter Biomedical Research Centre
  • Department of Health and Social Care

Zitieren

APA

Rautemaa-Richardson, R., Sobel, J. D., Stone, N., De Seta, F., Cassone, A., Vieira-Baptista, P., Comar, M., Warris, A., & Roselletti, E. (2026). State-of-the-Art Review: Managing Vulvovaginal Candidiasis. Clinical Infectious Diseases, 82(3), 371-382. https://doi.org/10.1093/cid/ciaf673

Vancouver

Rautemaa-Richardson R, Sobel JD, Stone N, De Seta F, Cassone A, Vieira-Baptista P, et al. State-of-the-Art Review: Managing Vulvovaginal Candidiasis. Clinical Infectious Diseases. 2026;82(3):371-382. doi:10.1093/cid/ciaf673

BibTeX
@article{RautemaaRichardson2026,
  author = {Rautemaa-Richardson, Riina and Sobel, Jack D and Stone, Neil and De Seta, Francesco and Cassone, Antonio and Vieira-Baptista, Pedro and Comar, Manola and Warris, Adilia and Roselletti, Elena},
  title = {State-of-the-Art Review: Managing Vulvovaginal Candidiasis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {3},
  pages = {371--382},
  doi = {10.1093/cid/ciaf673}
}
Kostenlos starten →